These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6298372)

  • 1. Time course of improved neuromuscular function following plasma exchange alone and plasma exchange with prednisone/azathioprine in myasthenia gravis.
    Milner-Brown HS; Miller RG
    J Neurol Sci; 1982 Dec; 57(2-3):357-68. PubMed ID: 6298372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma exchange and immunosuppressive drug treatment in myasthenia gravis: no evidence for synergy.
    Hawkey CJ; Newsom-Davis J; Vincent A
    J Neurol Neurosurg Psychiatry; 1981 Jun; 44(6):469-75. PubMed ID: 7276959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmapheresis and immunosuppressive drug therapy in myasthenia gravis.
    Dau PC; Lindstrom JM; Cassel CK; Denys EH; Shev EE; Spitler LE
    N Engl J Med; 1977 Nov; 297(21):1134-40. PubMed ID: 917042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy.
    Carter B; Harrison R; Lunt GG; Behan PO; Simpson JA
    J Neurol Neurosurg Psychiatry; 1980 May; 43(5):397-402. PubMed ID: 7420089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodies.
    Thorlacius S; Lefvert AK; Aarli JA; Gilhus NE; Halvorsen K; Hofstad H; Matre R; Tönder O
    Acta Neurol Scand; 1986 Dec; 74(6):486-90. PubMed ID: 3825504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid improvement of myasthenia gravis after plasma exchange.
    Nielsen VK; Paulson OB; Rosenkvist J; Holsøe E; Lefvert AK
    Ann Neurol; 1982 Feb; 11(2):160-9. PubMed ID: 6280584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remission of myasthenia gravis following plasma-exchange.
    Pinching AJ; Peters DK
    Lancet; 1976 Dec; 2(8000):1373-6. PubMed ID: 63848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma exchange in myasthenia gravis: electrophysiological studies.
    Campbell WW; Leshner RT; Swift TR
    Ann Neurol; 1980 Dec; 8(6):584-9. PubMed ID: 6260011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble adhesion molecules and cytokines in patients with myasthenia gravis treated by plasma exchange.
    Tesar V; Jelínková E; Jirsa M; Bakosová M; Pitha P; Chábová V
    Blood Purif; 2000; 18(2):115-20. PubMed ID: 10838470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amount of circulating acetylcholine receptor antibodies in the course of myasthenia, following thymectomy and in immunosuppressive therapy].
    Patzold U; Kalies I; Haas J; Ginda EM
    Nervenarzt; 1984 Aug; 55(8):426-31. PubMed ID: 6483064
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term effects of repeated plasma exchange in myasthenia gravis.
    Newsom-Davis J; Wilson SG; Vincent A; Ward CD
    Lancet; 1979 Mar; 1(8114):464-8. PubMed ID: 85055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized double-blind trial of prednisolone alone or with azathioprine in myasthenia gravis. Myasthenia Gravis Study Group.
    Palace J; Newsom-Davis J; Lecky B
    Neurology; 1998 Jun; 50(6):1778-83. PubMed ID: 9633727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
    Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
    Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Function of circulating antibody to acetylcholine receptor in myasthenia gravis: investigation by plasma exchange.
    Newsom-Davis J; Pinching AJ; Vincent A; Wilson SG
    Neurology; 1978 Mar; 28(3):266-72. PubMed ID: 564482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 2. Clinical and serological follow-up of individual patients.
    Oosterhuis HJ; Limburg PC; Hummel-Tappel E; The TH
    J Neurol Sci; 1983 Mar; 58(3):371-85. PubMed ID: 6842265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis and acetylcholine receptor: autoimmunity and steroid effects.
    Abramsky O
    Int J Neurol; 1980; 14(1):25-34. PubMed ID: 6293989
    [No Abstract]   [Full Text] [Related]  

  • 18. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis in myasthenia gravis.
    Dau PC
    Prog Clin Biol Res; 1982; 88():265-85. PubMed ID: 7100216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis.
    Behan PO; Shakir RA; Simpson JA; Burnett AK; Allan TL; Haase G
    Lancet; 1979 Sep; 2(8140):438-40. PubMed ID: 89500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.